Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000253144 is formally identified by GeneCards and Ensembl as a pseudogene named "Pseudogene Similat To Part Of Cold Shock Domain Containing E1, RNA-Binding CSDE1." Pseudogenes are genetic sequences similar to protein-coding genes but typically lack functional protein products. This pseudogene is likely related by sequence to the functional gene CSDE1 ("Cold shock domain-containing protein E1"), an RNA-binding protein involved in post-transcriptional regulation, cancer biology, cell cycle, and apoptosis[2][3][1][9]. However, ENSG00000253144 itself does not encode a functional protein, has no recognized biological activity, is not considered a receptor or therapeutic target, and its name contains a typographical error ("Similat" instead of "Similar")[9][5]. There is no evidence for involvement in disease, drug interaction, use as a biomarker, or molecular mechanism of action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene Similat To Part Of Cold Shock Domain Containing E1, RNA-Binding CSDE1 (ENSG00000253144).